These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 31083747)
1. Patients with gastric MALT lymphoma revealing persisting endoscopic abnormalities after successful eradication of Helicobacter pylori can be safely managed by a watch-and-wait strategy. Fischbach W; Dorlöchter C Z Gastroenterol; 2019 May; 57(5):593-599. PubMed ID: 31083747 [TBL] [Abstract][Full Text] [Related]
2. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Fischbach W; Goebeler ME; Ruskone-Fourmestraux A; Wündisch T; Neubauer A; Raderer M; Savio A; Gut; 2007 Dec; 56(12):1685-7. PubMed ID: 17639089 [TBL] [Abstract][Full Text] [Related]
3. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M; Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816 [TBL] [Abstract][Full Text] [Related]
5. Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis. Al-Taie O; Al-Taie E; Fischbach W Z Gastroenterol; 2014 Dec; 52(12):1389-93. PubMed ID: 25474277 [TBL] [Abstract][Full Text] [Related]
6. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status. Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851 [TBL] [Abstract][Full Text] [Related]
7. Gastric MALT lymphoma - update on diagnosis and treatment. Fischbach W Best Pract Res Clin Gastroenterol; 2014 Dec; 28(6):1069-77. PubMed ID: 25439072 [TBL] [Abstract][Full Text] [Related]
8. Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: true relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy. Savio A; Zamboni G; Capelli P; Negrini R; Santandrea G; Scarpa A; Fuini A; Pasini F; Ambrosetti A; Paterlini A; Buffoli F; Angelini GP; Cesari P; Rolfi F; Graffeo M; Pascarella A; Valli M; Mombello A; Ederle A; Franzin G Recent Results Cancer Res; 2000; 156():116-24. PubMed ID: 10802871 [TBL] [Abstract][Full Text] [Related]
9. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369 [TBL] [Abstract][Full Text] [Related]
10. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Sackmann M; Morgner A; Rudolph B; Neubauer A; Thiede C; Schulz H; Kraemer W; Boersch G; Rohde P; Seifert E; Stolte M; Bayerdoerffer E Gastroenterology; 1997 Oct; 113(4):1087-90. PubMed ID: 9322502 [TBL] [Abstract][Full Text] [Related]
11. Treatment Strategy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. Nakamura S; Matsumoto T Gastroenterol Clin North Am; 2015 Sep; 44(3):649-60. PubMed ID: 26314674 [TBL] [Abstract][Full Text] [Related]
12. Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type. Morgner A; Miehlke S; Stolte M; Neubauer A; Alpen B; Thiede C; Klann H; Hierlmeier FX; Ell C; Ehninger G; Bayerdörffer E World J Gastroenterol; 2001 Apr; 7(2):248-53. PubMed ID: 11819769 [TBL] [Abstract][Full Text] [Related]
13. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopic ultrasonography. Nobre-Leitão C; Lage P; Cravo M; Cabeçadas J; Chaves P; Alberto-Santos A; Correia J; Soares J; Costa-Mira F Am J Gastroenterol; 1998 May; 93(5):732-6. PubMed ID: 9625118 [TBL] [Abstract][Full Text] [Related]
14. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Fischbach W; Goebeler-Kolve ME; Dragosics B; Greiner A; Stolte M Gut; 2004 Jan; 53(1):34-7. PubMed ID: 14684573 [TBL] [Abstract][Full Text] [Related]
15. Treatment of low-grade gastric MALT lymphoma using Helicobacter pylori eradication. Grgov S; Katić V; Krstić M; Nagorni A; Radovanović-Dinić B; Tasić T Vojnosanit Pregl; 2015 May; 72(5):431-6. PubMed ID: 26165051 [TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of gastric lymphoma after stomach conserving treatment. Fischbach W Best Pract Res Clin Gastroenterol; 2010 Feb; 24(1):71-7. PubMed ID: 20206110 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Follow-up of the histological and molecular response]. Montalbán C; Manzanal A; Boixeda D; Redondo C; Alvarez I; Frutos B; Calleja JL; Sánchez-Godoy P; Bellas C Med Clin (Barc); 1998 Jan; 110(2):41-4. PubMed ID: 9534129 [TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori and gastric mucosa-associated lymphoid tissue lymphoma: recent progress in pathogenesis and management. Nakamura S; Matsumoto T World J Gastroenterol; 2013 Dec; 19(45):8181-7. PubMed ID: 24363507 [TBL] [Abstract][Full Text] [Related]
20. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]